title: Antidrug antibodies to tumour necrosis factor specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective; comment on the article by Vincent et al.
authors.forename: Alfons A
authors.initials: AA
authors.lastname: den Broeder
authors.forename: Aatke
authors.initials: A
authors.lastname: van der Maas
authors.forename: Bart J F
authors.initials: BJ
authors.lastname: van den Bemt
mesh_terms: D000818:Animals; D018501:Antirheumatic Agents / Q000276:immunology*; D001688:Biological Products / Q000276:immunology*; D006801:Humans; D007154:Immune System Diseases / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D001688:Biological Products; D014409:Tumor Necrosis Factor-alpha
keywords: Adult Onset Still's Disease; Amyloidosis; Analgesics